130 related articles for article (PubMed ID: 23337712)
1. Retinal vein occlusion: genetic predisposition and systemic risk factors.
Giannaki K; Politou M; Rouvas A; Merkouri E; Travlou A; Theodosiadis P; Gialeraki A
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):279-83. PubMed ID: 23337712
[TBL] [Abstract][Full Text] [Related]
2. Association study of high-frequency variants of
Fernández-Vega B; Álvarez L; García M; Artime E; González Fernández A; Fernández-Vega C; Nicieza J; Vega JA; González-Iglesias H
Ophthalmic Genet; 2019 Aug; 40(4):342-349. PubMed ID: 31418317
[No Abstract] [Full Text] [Related]
3. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
4. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.
Arsène S; Delahousse B; Regina S; Le Lez ML; Pisella PJ; Gruel Y
Thromb Haemost; 2005 Jul; 94(1):101-6. PubMed ID: 16113792
[TBL] [Abstract][Full Text] [Related]
6. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management.
Yau JW; Lee P; Wong TY; Best J; Jenkins A
Intern Med J; 2008 Dec; 38(12):904-10. PubMed ID: 19120547
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with retinal-vein occlusion in Hispanics.
Appiah AP; Greenidge KC
Ann Ophthalmol; 1987 Aug; 19(8):307-9, 312. PubMed ID: 3662315
[TBL] [Abstract][Full Text] [Related]
8. Association of systemic diseases with retinal vein occlusive disease.
Shrestha RK; Shrestha JK; Koirala S; Shah DN
JNMA J Nepal Med Assoc; 2006; 45(162):244-8. PubMed ID: 17189969
[TBL] [Abstract][Full Text] [Related]
9. Retinal vein occlusion and traditional risk factors for atherosclerosis.
O'Mahoney PR; Wong DT; Ray JG
Arch Ophthalmol; 2008 May; 126(5):692-9. PubMed ID: 18474782
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with retinal vein occlusion.
Martínez F; Furió E; Fabiá MJ; Pérez AV; González-Albert V; Rojo-Martínez G; Martínez-Larrad MT; Mena-Martín FJ; Soriguer F; Serrano-Ríos M; Chaves FJ; Martín-Escudero JC; Redón J; García-Fuster MJ
Int J Clin Pract; 2014 Jul; 68(7):871-81. PubMed ID: 24548738
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic risk factors in patients with central retinal vein occlusion.
Marcucci R; Bertini L; Giusti B; Brunelli T; Fedi S; Cellai AP; Poli D; Pepe G; Abbate R; Prisco D
Thromb Haemost; 2001 Sep; 86(3):772-6. PubMed ID: 11583306
[TBL] [Abstract][Full Text] [Related]
12. The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.
Rehak M; Krcova V; Slavik L; Fric E; Langova K; Ulehlova J; Rehak J
Can J Ophthalmol; 2010 Apr; 45(2):171-5. PubMed ID: 20379305
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms and retinal vein occlusion in an Italian population.
De Polo L; Maltese PE; Rigoni E; Bertelli M; Cecchin S; Staurenghi G; Stoppa G
Genet Mol Res; 2015 Oct; 14(4):13337-41. PubMed ID: 26535647
[TBL] [Abstract][Full Text] [Related]
14. Retinal vein occlusion and the risk of stroke development: a five-year follow-up study.
Ho JD; Liou SW; Lin HC
Am J Ophthalmol; 2009 Feb; 147(2):283-290.e2. PubMed ID: 18835470
[TBL] [Abstract][Full Text] [Related]
15. Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.
Kida T
Biomed Res Int; 2017; 2017():4816527. PubMed ID: 28904960
[TBL] [Abstract][Full Text] [Related]
16. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion.
Glueck CJ; Wang P; Bell H; Rangaraj V; Goldenberg N
Clin Appl Thromb Hemost; 2005 Oct; 11(4):375-89. PubMed ID: 16244763
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
Rehak M; Rehak J; Müller M; Faude S; Faude F; Siegemund A; Krcova V; Slavik L; Hasenclever D; Scholz M; Wiedemann P
Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
[TBL] [Abstract][Full Text] [Related]
18. Coagulation disorders and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
Thromb Haemost; 2010 Feb; 103(2):299-305. PubMed ID: 20126828
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
McGimpsey SJ; Woodside JV; Cardwell C; Cahill M; Chakravarthy U
Ophthalmology; 2009 Sep; 116(9):1778-1787.e1. PubMed ID: 19729099
[TBL] [Abstract][Full Text] [Related]
20. Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.
Weger M; Steinbrugger I; Renner W; Pöschl EM; Brockmann T; Rabensteiner DF; El-Shabrawi Y; Haas A
Curr Eye Res; 2013 Dec; 38(12):1278-82. PubMed ID: 23972066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
